Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026)
Kodiak Sciences (KOD) posted Change in Accured Expenses of $4.6 million for Q1 2026, up 228000.0% on a QoQ basis from -$2000.0 in Q4 2025, and up 93.55% year-over-year from $2.4 million in Q1 2025.
Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 93.55% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 1913.33% YoY) and the FY2025 annual result came in at $9.3 million, up 225.8% from the prior year.
- Change in Accured Expenses was $4.6 million for Q1 2026 at Kodiak Sciences, up from -$2000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $13.7 million in Q1 2022 and bottomed at -$12.2 million in Q2 2022.
- A 5-year average of -$511352.9 and a median of $408000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 403.28% — and 2025, when it soared 398.59%.
- Kodiak Sciences' Change in Accured Expenses stood at -$7.6 million in 2022, then soared by 39.27% to -$4.6 million in 2023, then soared by 108.79% to $408000.0 in 2024, then sank by 100.49% to -$2000.0 in 2025, then soared by 228000.0% to $4.6 million in 2026.
- Business Quant data shows KOD's Change in Accured Expenses at $4.6 million in Q1 2026, -$2000.0 in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | 4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.56 Mn |
| Mar 31, 2026 | 4.56 Mn |
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 5.64 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 408,000.00 |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -3.32 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Dec 31, 2023 | -4.64 Mn |